Literature DB >> 7641751

Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.

R A Dierckx1, A Dobbeleir, B A Pickut, L Timmermans, I Dierckx, A Vervaet, J Vandevivere, W Deberdt, P P De Deyn.   

Abstract

A comparative interim analysis was performed of clinical parameters, computed tomographic (CT) scan results and technetium-99m hexamethylpropylene amine oxime single-photon emission tomography (SPET) findings obtained within 12 h of acute supratentorial ischaemic infarction. First, the applicability for SPET semiquantification in this study of the "method of Mountz", simultaneously accounting for extent and degrees of hypoperfusion by expressing deficits as millilitre of zero perfusion, was considered. Next, the relative contributions of perfusion SPET and CT scan in the acute stage of ischaemic infarction were compared in 27 patients (mean age 68.8 years). Finally, the correlation of SPET lesions with clinical parameters at onset was evaluated. The method of Mountz represents a workable, accurate virtual parameter, with the assumption that the contralateral brain region remains uninvolved. Interobserver reproducibility in 12 SPET studies, with lesions varying between 6 and 369 cc, showed a correlation coefficient r of 0.99. In practice, because of inconstant distribution of activities in the brain, the method can only be applied slice by slice and not on the total global volume. While the mean delay since the onset of symptomatology was approximately 7 h for both SPET and CT scan, SPET showed lesions concordant with the clinical neurological findings in 100% and CT scan in only 48%. One could hypothesize that SPET examinations performed later would show larger functional defects, because of the development of additional functional changes secondary to biochemical alterations. However, in this regard no statistically significant differences were found between two subproups, taking the median of delay before SPET examination as cut-off.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641751     DOI: 10.1007/bf00839057

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  24 in total

1.  Single-photon emission computed tomography and early death in acute ischemic stroke.

Authors:  M Limburg; E A van Royen; A Hijdra; J F de Bruïne; B W Verbeeten
Journal:  Stroke       Date:  1990-08       Impact factor: 7.914

2.  Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke.

Authors:  F Giubilei; G L Lenzi; V Di Piero; C Pozzilli; P Pantano; S Bastianello; C Argentino; C Fieschi
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

3.  The Frenchay Aphasia Screening Test: a short, simple test for aphasia appropriate for non-specialists.

Authors:  P M Enderby; V A Wood; D T Wade; R L Hewer
Journal:  Int Rehabil Med       Date:  1987

4.  A method of analysis of SPECT blood flow image data for comparison with computed tomography.

Authors:  J M Mountz
Journal:  Clin Nucl Med       Date:  1989-03       Impact factor: 7.794

5.  Clinical experience with Tc-99m HM-PAO high resolution SPECT of the brain in patients with cerebrovascular accidents.

Authors:  M De Roo; L Mortelmans; P Devos; A Verbruggen; G Wilms; H Carton; V Wils; R Van den Bergh
Journal:  Eur J Nucl Med       Date:  1989

6.  Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT.

Authors:  J M Mountz; J G Modell; N L Foster; E S DuPree; R J Ackermann; N A Petry; L E Bluemlein; D E Kuhl
Journal:  J Nucl Med       Date:  1990-01       Impact factor: 10.057

7.  Sensitivity and specificity of 99Tcm-HMPAO single-headed SPECT in dementia.

Authors:  R A Dierckx; M Vandewoude; J Saerens; T Hartoko; P Marien; I Capiau; A Vervaet; A Dobbeleir; P P De Deyn
Journal:  Nucl Med Commun       Date:  1993-09       Impact factor: 1.690

8.  Prolonged disturbances of regional cerebral blood flow in transient ischemic attacks.

Authors:  A Hartmann
Journal:  Stroke       Date:  1985 Nov-Dec       Impact factor: 7.914

9.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057

10.  Transient ischemic attacks associated with amfepramone therapy: a case report.

Authors:  R Crols; R Dierckx; J Saerens; P P De Deyn
Journal:  Funct Neurol       Date:  1993 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.